DAVID M. STACK - 16 Nov 2021 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role: CEO and Chairman, Director
Signature: /s/ Kristen Williams, Attorney-in-Fact
Issuer symbol: PCRX
Transactions as of: 16 Nov 2021
Net transactions value: +$162,150
Form type: 4
Filing time: 18 Nov 2021, 15:22:06 UTC
Previous filing: 05 Aug 2021
Next filing: 13 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PCRX	Common Stock	Options Exercise	$162,150	+15,000	+19%	$10.81	94,085	16 Nov 2021	Direct	F1
holding	PCRX	Common Stock						97,273	16 Nov 2021	By Three Colleens Investment, LLC	F2
holding	PCRX	Common Stock						18,596	16 Nov 2021	By Stack Schroon Mohawk FLP	F2
holding	PCRX	Common Stock						315	16 Nov 2021	LCK Investment LLC	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PCRX	Stock Option (Right to Buy)	Options Exercise	$0	-15,000	-17%	$0.000000	73,670	16 Nov 2021	Common Stock	15,000	$10.81	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 129 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.
F2	Mr. Stack and his wife are the owners of each of Three Colleens Investment, LLC and LCK Investment LLC. Mr. Stack is the general partner of Stack Schroon Mohawk FLP.
F3	The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and as to the remaining shares in successive equal monthly installments for the subsequent 36 months.